Craniopharyngiomas - the utility of contrast medium enhancement for MR imaging at 1.5 T

J. K. Hald, O. P. Eldevik, James A Brunberg, W. F. Chandler

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To evaluate the efficacy of i.v. contrast medium administration in MR imaging at 1.5 T in patients with craniopharyngiomas, MR studies of 10 men and 6 women with pathologically proven craniopharyngiomas were made. The MR images were obtained as 3- to 5-mm-thick coronal (n = 13) or axial (n = 3) T1-weighted images (T1WI) prior to and following i.v. Gd-DTPA administration. Proton density- (PD) and T2-weighted images (T2WI) were also obtained. Conspicuity of tumor margins, cystic versus solid components, size, location and effect upon adjacent structures were separately characterized in all imaging sequences. In 6 patients contrast medium-enhanced T1WI, PD and T2WI demonstrated cystic tumor components not seen on unenhanced T1WI. There were significant differences (p < 0.004) on 2-tailed Student's t-test comparing tumor conspicuity on contrast medium-enhanced T1WI with unenhanced T1WI, PD and T2WI. Optimal tumor delineation on MR imaging of patients with craniopharyngiomas justifies the use of i.v. contrast medium.

Original languageEnglish (US)
Pages (from-to)520-525
Number of pages6
JournalActa Radiologica
Volume35
Issue number6
StatePublished - Nov 1994
Externally publishedYes

Fingerprint

Contrast media
Craniopharyngioma
Contrast Media
Tumors
Imaging techniques
Protons
Neoplasms
Gadolinium DTPA
Students

ASJC Scopus subject areas

  • Engineering(all)
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Craniopharyngiomas - the utility of contrast medium enhancement for MR imaging at 1.5 T. / Hald, J. K.; Eldevik, O. P.; Brunberg, James A; Chandler, W. F.

In: Acta Radiologica, Vol. 35, No. 6, 11.1994, p. 520-525.

Research output: Contribution to journalArticle

Hald, J. K. ; Eldevik, O. P. ; Brunberg, James A ; Chandler, W. F. / Craniopharyngiomas - the utility of contrast medium enhancement for MR imaging at 1.5 T. In: Acta Radiologica. 1994 ; Vol. 35, No. 6. pp. 520-525.
@article{d8fd71b983b94ad192605d7d7bd6cc15,
title = "Craniopharyngiomas - the utility of contrast medium enhancement for MR imaging at 1.5 T",
abstract = "To evaluate the efficacy of i.v. contrast medium administration in MR imaging at 1.5 T in patients with craniopharyngiomas, MR studies of 10 men and 6 women with pathologically proven craniopharyngiomas were made. The MR images were obtained as 3- to 5-mm-thick coronal (n = 13) or axial (n = 3) T1-weighted images (T1WI) prior to and following i.v. Gd-DTPA administration. Proton density- (PD) and T2-weighted images (T2WI) were also obtained. Conspicuity of tumor margins, cystic versus solid components, size, location and effect upon adjacent structures were separately characterized in all imaging sequences. In 6 patients contrast medium-enhanced T1WI, PD and T2WI demonstrated cystic tumor components not seen on unenhanced T1WI. There were significant differences (p < 0.004) on 2-tailed Student's t-test comparing tumor conspicuity on contrast medium-enhanced T1WI with unenhanced T1WI, PD and T2WI. Optimal tumor delineation on MR imaging of patients with craniopharyngiomas justifies the use of i.v. contrast medium.",
author = "Hald, {J. K.} and Eldevik, {O. P.} and Brunberg, {James A} and Chandler, {W. F.}",
year = "1994",
month = "11",
language = "English (US)",
volume = "35",
pages = "520--525",
journal = "Acta Radiologica",
issn = "0284-1851",
publisher = "SAGE Publications Ltd",
number = "6",

}

TY - JOUR

T1 - Craniopharyngiomas - the utility of contrast medium enhancement for MR imaging at 1.5 T

AU - Hald, J. K.

AU - Eldevik, O. P.

AU - Brunberg, James A

AU - Chandler, W. F.

PY - 1994/11

Y1 - 1994/11

N2 - To evaluate the efficacy of i.v. contrast medium administration in MR imaging at 1.5 T in patients with craniopharyngiomas, MR studies of 10 men and 6 women with pathologically proven craniopharyngiomas were made. The MR images were obtained as 3- to 5-mm-thick coronal (n = 13) or axial (n = 3) T1-weighted images (T1WI) prior to and following i.v. Gd-DTPA administration. Proton density- (PD) and T2-weighted images (T2WI) were also obtained. Conspicuity of tumor margins, cystic versus solid components, size, location and effect upon adjacent structures were separately characterized in all imaging sequences. In 6 patients contrast medium-enhanced T1WI, PD and T2WI demonstrated cystic tumor components not seen on unenhanced T1WI. There were significant differences (p < 0.004) on 2-tailed Student's t-test comparing tumor conspicuity on contrast medium-enhanced T1WI with unenhanced T1WI, PD and T2WI. Optimal tumor delineation on MR imaging of patients with craniopharyngiomas justifies the use of i.v. contrast medium.

AB - To evaluate the efficacy of i.v. contrast medium administration in MR imaging at 1.5 T in patients with craniopharyngiomas, MR studies of 10 men and 6 women with pathologically proven craniopharyngiomas were made. The MR images were obtained as 3- to 5-mm-thick coronal (n = 13) or axial (n = 3) T1-weighted images (T1WI) prior to and following i.v. Gd-DTPA administration. Proton density- (PD) and T2-weighted images (T2WI) were also obtained. Conspicuity of tumor margins, cystic versus solid components, size, location and effect upon adjacent structures were separately characterized in all imaging sequences. In 6 patients contrast medium-enhanced T1WI, PD and T2WI demonstrated cystic tumor components not seen on unenhanced T1WI. There were significant differences (p < 0.004) on 2-tailed Student's t-test comparing tumor conspicuity on contrast medium-enhanced T1WI with unenhanced T1WI, PD and T2WI. Optimal tumor delineation on MR imaging of patients with craniopharyngiomas justifies the use of i.v. contrast medium.

UR - http://www.scopus.com/inward/record.url?scp=0028534473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028534473&partnerID=8YFLogxK

M3 - Article

C2 - 7946671

AN - SCOPUS:0028534473

VL - 35

SP - 520

EP - 525

JO - Acta Radiologica

JF - Acta Radiologica

SN - 0284-1851

IS - 6

ER -